GSK Plc (GLAXF)
GSK Market Cap : 109.89B for April 2, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Silence Therapeutics Plc | 283.40M |
| Adaptimmune Therapeutics Plc | 5.301M |
| Biodexa Pharmaceuticals Plc | 1.057M |
| Oxford Biomedica Plc | 849.92M |
| NuCana Plc | 7.181M |
Market Cap Related Metrics
| PE Ratio | 15.00 |
| PS Ratio | 2.618 |
| PEG Ratio | 0.1141 |
| Price to Book Value | 4.989 |
| Price to Free Cash Flow | 19.65 |
| Price | 26.75 |
| Earnings Yield | 6.67% |
| PEGY Ratio | 0.1141 |
| Operating PE Ratio | 11.60 |
| Normalized PE Ratio | 13.89 |